Annual CFF
$7.41 M
+$7.44 M+28611.54%
December 1, 2023
Summary
- As of February 12, 2025, PHIO annual cash flow from financing activities is $7.41 million, with the most recent change of +$7.44 million (+28611.54%) on December 1, 2023.
- During the last 3 years, PHIO annual CFF has fallen by -$8.72 million (-54.05%).
- PHIO annual CFF is now -65.87% below its all-time high of $21.72 million, reached on December 31, 2021.
Performance
PHIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.65 M
+$2.65 M+100.00%
September 1, 2024
Summary
- As of February 12, 2025, PHIO quarterly cash flow from financing activities is $2.65 million, with the most recent change of +$2.65 million (+100.00%) on September 1, 2024.
- Over the past year, PHIO quarterly CFF has increased by +$2.65 million (+100.00%).
- PHIO quarterly CFF is now -87.82% below its all-time high of $21.72 million, reached on March 31, 2021.
Performance
PHIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$5.04 M
+$2.65 M+110.25%
September 1, 2024
Summary
- As of February 12, 2025, PHIO TTM cash flow from financing activities is $5.04 million, with the most recent change of +$2.65 million (+110.25%) on September 1, 2024.
- Over the past year, PHIO TTM CFF has increased by +$32.00 thousand (+0.64%).
- PHIO TTM CFF is now -82.80% below its all-time high of $29.32 million, reached on March 31, 2021.
Performance
PHIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PHIO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +100.0% | +0.6% |
| 3 y3 years | -54.0% | +100.0% | +0.6% |
| 5 y5 years | -60.6% | +100.0% | +0.6% |
PHIO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -65.9% | >+9999.0% | -47.6% | +7060.5% | -76.8% | >+9999.0% |
| 5 y | 5-year | -65.9% | >+9999.0% | -87.8% | +7060.5% | -82.8% | >+9999.0% |
| alltime | all time | -65.9% | >+9999.0% | -87.8% | +129.2% | -82.8% | +296.4% |
Phio Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.65 M(>+9900.0%) | $5.04 M(+110.3%) |
| Jun 2024 | - | $0.00(-100.0%) | $2.40 M(-67.8%) |
| Mar 2024 | - | -$4000.00(-100.2%) | $7.45 M(+0.5%) |
| Dec 2023 | $7.41 M(<-9900.0%) | $2.40 M(>+9900.0%) | $7.41 M(+47.9%) |
| Sep 2023 | - | $0.00(-100.0%) | $5.01 M(+0.1%) |
| Jun 2023 | - | $5.05 M(<-9900.0%) | $5.01 M(<-9900.0%) |
| Mar 2023 | - | -$38.00 K(-2000.0%) | -$39.00 K(+50.0%) |
| Dec 2022 | -$26.00 K(-100.1%) | $2000.00(-166.7%) | -$26.00 K(-10.3%) |
| Sep 2022 | - | -$3000.00(<-9900.0%) | -$29.00 K(+11.5%) |
| Jun 2022 | - | $0.00(-100.0%) | -$26.00 K(0.0%) |
| Mar 2022 | - | -$25.00 K(+2400.0%) | -$26.00 K(-100.1%) |
| Dec 2021 | $21.72 M(+34.7%) | -$1000.00(<-9900.0%) | $21.72 M(-0.0%) |
| Sep 2021 | - | $0.00(0.0%) | $21.72 M(+0.1%) |
| Jun 2021 | - | $0.00(-100.0%) | $21.71 M(-26.0%) |
| Mar 2021 | - | $21.72 M(>+9900.0%) | $29.32 M(+81.7%) |
| Dec 2020 | $16.13 M(+1989.5%) | $0.00(-100.0%) | $16.13 M(-4.5%) |
| Sep 2020 | - | -$17.00 K(-100.2%) | $16.90 M(+0.2%) |
| Jun 2020 | - | $7.61 M(-10.8%) | $16.86 M(+82.0%) |
| Mar 2020 | - | $8.54 M(+1014.4%) | $9.27 M(+1100.1%) |
| Dec 2019 | $772.00 K(-95.9%) | $766.00 K(-1492.7%) | $772.00 K(-94.2%) |
| Sep 2019 | - | -$55.00 K(-405.6%) | $13.40 M(+0.1%) |
| Jun 2019 | - | $18.00 K(-58.1%) | $13.38 M(-25.4%) |
| Mar 2019 | - | $43.00 K(-99.7%) | $17.93 M(-4.7%) |
| Dec 2018 | $18.82 M | $13.39 M(<-9900.0%) | $18.82 M(+224.6%) |
| Sep 2018 | - | -$68.00 K(-101.5%) | $5.80 M(+0.1%) |
| Jun 2018 | - | $4.57 M(+390.2%) | $5.79 M(+373.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $932.00 K(+154.6%) | $1.22 M(+319.2%) |
| Dec 2017 | $292.00 K(-97.1%) | $366.00 K(-594.6%) | $292.00 K(-97.1%) |
| Sep 2017 | - | -$74.00 K(<-9900.0%) | $9.98 M(-2.2%) |
| Jun 2017 | - | $0.00(0.0%) | $10.20 M(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) | $10.20 M(0.0%) |
| Dec 2016 | $10.20 M(+7.5%) | $10.05 M(+6512.5%) | $10.20 M(+2954.8%) |
| Sep 2016 | - | $152.00 K(-16.5%) | $334.00 K(-96.5%) |
| Dec 2015 | $9.49 M(+387.7%) | $182.00 K(+1416.7%) | $9.49 M(+2.3%) |
| Sep 2015 | - | $12.00 K(-99.9%) | $9.28 M(+0.1%) |
| Jun 2015 | - | $9.24 M(>+9900.0%) | $9.27 M(+361.0%) |
| Mar 2015 | - | $64.00 K(-313.3%) | $2.01 M(+3.3%) |
| Dec 2014 | $1.95 M(-87.6%) | -$30.00 K(<-9900.0%) | $1.95 M(-2.9%) |
| Sep 2014 | - | $0.00(-100.0%) | $2.00 M(+0.4%) |
| Jun 2014 | - | $1.98 M(>+9900.0%) | $2.00 M(+8587.0%) |
| Mar 2014 | - | $0.00(-100.0%) | $23.00 K(-99.9%) |
| Dec 2013 | $15.67 M(+62.0%) | $28.00 K(-500.0%) | $15.67 M(+0.2%) |
| Sep 2013 | - | -$7000.00(-450.0%) | $15.64 M(0.0%) |
| Jun 2013 | - | $2000.00(-100.0%) | $15.64 M(-35.7%) |
| Mar 2013 | - | $15.64 M(<-9900.0%) | $24.30 M(+151.3%) |
| Dec 2012 | $9.67 M(+160.4%) | -$3000.00(-57.1%) | $9.67 M(-23.4%) |
| Sep 2012 | - | -$7000.00(-100.1%) | $12.62 M(-16.8%) |
| Jun 2012 | - | $8.67 M(+758.4%) | $15.17 M(-690.7%) |
| Mar 2012 | - | $1.01 M(-65.8%) | -$2.57 M(-169.2%) |
| Dec 2011 | $3.71 M | $2.95 M(+16.2%) | $3.71 M(+386.6%) |
| Sep 2011 | - | $2.54 M(-128.0%) | $763.00 K(-143.0%) |
| Jun 2011 | - | -$9.07 M(-224.4%) | -$1.78 M(-124.4%) |
| Mar 2011 | - | $7.29 M | $7.29 M |
FAQ
- What is Phio Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual CFF year-on-year change?
- What is Phio Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly CFF year-on-year change?
- What is Phio Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals TTM CFF year-on-year change?
What is Phio Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of PHIO is $7.41 M
What is the all time high annual CFF for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual cash flow from financing activities is $21.72 M
What is Phio Pharmaceuticals annual CFF year-on-year change?
Over the past year, PHIO annual cash flow from financing activities has changed by +$7.44 M (+28611.54%)
What is Phio Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of PHIO is $2.65 M
What is the all time high quarterly CFF for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly cash flow from financing activities is $21.72 M
What is Phio Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, PHIO quarterly cash flow from financing activities has changed by +$2.65 M (+100.00%)
What is Phio Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of PHIO is $5.04 M
What is the all time high TTM CFF for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high TTM cash flow from financing activities is $29.32 M
What is Phio Pharmaceuticals TTM CFF year-on-year change?
Over the past year, PHIO TTM cash flow from financing activities has changed by +$32.00 K (+0.64%)